Asthma and COPD Drugs Market Analysis by SWOT, Investment, Future Growth and Major Key Players 2020 to 2027

Asthma and COPD Drugs Market Highlights

The Asthma and COPD Drugs Market is projected to reach USD 34,374.23 Million by 2030 at 4.20% CAGR during the forecast period 2022-2030. Asthma is a type of inflammatory disease that affects the lungs and makes breathing difficult. It is one of the common chronic conditions affecting many people across the globe. COPD or chronic obstructive pulmonary disease is an umbrella term used for a group of respiratory diseases such as emphysema and chronic bronchitis.

Segment Analysis

The Global Asthma and COPD Drugs Market have been segmented by disease, product, route of administration, and distribution channel. The market, based on disease, has been bifurcated into asthma and COPD.

Based on product, asthma and COPD drugs market has been segregated into long-term asthma control medications and quick-relief medications. The long-term asthma control medications are further segmented into combination drugs, anticholinergics, inhaled corticosteroids, long-acting beta-agonists, theophylline, and others. The combination drugs are further segregated into Seretide/Advair, Symbicort, Relvar/Breo Ellipta, Flutiform, Dulera, and others. Anticholinergics is further sub-segmented into Spiriva and others. Inhaled corticosteroids are further segmented into Pulmicort, Flovent, Qvar, and others.

The quick-relief medications have been further segmented into short-acting beta-agonists, oral & intravenous corticosteroids, ipratropium bromide (Atrovent), and others. Short-acting beta-agonists have been further segregated into Proair and Ventolin.

Global asthma and COPD drugs market, based on the route of administration, has been segmented into oral, inhaled, and others. Based on the distribution channels, global asthma and COPD drugs market report has been segmented into retail pharmacies, hospital pharmacies, and online pharmacies.

Regional Analysis

Global asthma and COPD drugs market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas are likely to dominate global asthma and COPD drugs market. This can be attributed to the rising patient population suffering from asthma and COPD in the region. According to the American Academy of Allergy Asthma & Immunology, in 2016, approximately 8.3% of children in the US had asthma. Moreover, the rising health expenditure per person and increasing demand for advanced treatment options are also expected to drive market growth.

The European market for asthma and COPD drugs is expected to be the second largest during the review period. The growing awareness of asthma and COPD in Europe is expected to boost the growth of the regional market. For instance, in April 2017, the “United Action for Allergy and Asthma” was launched in Europe to raise awareness regarding asthma in the continent. Additionally, the prevalence of asthma and COPD is also increasing in Europe, which is also fuelling market growth.

 

Asia-Pacific is estimated to be the fastest-growing market owing to the rising awareness regarding COPD and asthma in the region. For instance, Koninklijke Philips launched a campaign in May 2019, for raising awareness of asthma in India on World Asthma Day. Moreover, a high prevalence of asthma and COPD is also positively affecting the market growth.

The market in the Middle East & Africa is expected to witness steady growth due to the rising patient population suffering from asthma and COPD in the Middle Eastern countries.

Key Players

The Global Asthma and COPD Drugs Market Players - GlaxoSmithKline plc (UK), AstraZeneca (UK), Boehringer Ingelheim International GmbH (Germany), and Chiesi Farmaceutici SpA (Italy).

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com 

Comments

Post a Comment

Popular posts from this blog

Macrolide Antibiotics Market Competitive Landscape, Future Plans and Global Trends by Forecast 2030

  Macrolide Antibiotics Market Highlights Macrolides such as azithromycin, clarithromycin, and erythromycin are a class of antibiotics that inhibit protein synthesis. It acts as a bacteriostatic agent against many strains of corynebacterial, listeria, moxicella, streptococci, Neisseria meningitides, Staphylococci, Clostridia, and Haemophilus sp. It is used for the treatment of bacterial infections, such as nose, ear, and throat infections, chest infections, skin infections as well as mouth and dental infections. They are also used as an alternative to penicillin. The global macrolide antibiotics market is expected to show a sharp growth over the forecast period owing to an increasing demand for macrolide across the globe. Rising prevalence of bacterial skin infections and rising number of dermatology clinics also favour the market growth.  According to a study published in the Journal of the American College of Cardiology, macrolide antibiotics may increase the ...
Read more

Atorvastatin API Market Competitive Landscape, Future Plans and Global Trends by Forecast 2030

  Atorvastatin API Market Highlights The hypercholesterolemia segment is expected to lead the market and register a substantial CAGR to reach USD 2,10,753.23 thousand by the end of 2023. High prevalence of hypercholesterolemia is expected to drive the market growth. Additionally, the segment is projected to exhibit the highest CAGR of 4.09% from 2018 to 2023. The atorvastatin API market is anticipated to reach USD 2,852.3 Million by 2030 at 7.50% CAGR during the forecast period 2022-2030. North America accounted for the largest market share of 40.64% in 2017, and the regional market is projected to register a CAGR of 3.10% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The Chinese market is projected to exhibit the highest growth rate of 5.86% during the forecast period from 2022 to 2030. Atorvastatin API Market Segmentation The atorvastatin API market report has been studied extensively by MRFR experts, with respect to applications. ...
Read more

Nutrigenomics Market | Global Analysis, Statistics, Revenue, Demand and Trend Analysis Research Report by 2030

Market Highlights Following the analysis of the latest trends across the globe, Market Research Future (MRFR) states that the nutrigenomics market is projected to reach the valuation of  USD 464.76 Million by 2030 . In addition, the market is expected to surge at a growth rate of  15.70% during the forecast period ( 2022-2030 ). The Nutrigenomics market is one that has emerged in the past few years, carrying with it a massive potential. With the global statistics for obesity, lifestyle diseases and the ever-increasing demand for effective cosmetic treatments, nutrigenics has risen up as a potential treatment option. Growth Drivers and Key Restraints The boost in the awareness levels among consumers coupled with the rising prevalence of obesity across the globe is predicted to be a crucial factor elevating the market position of nutrigenomics. The surging trend of personalized diet, particularly among athletes will also be beneficial for the market in the near future. ...
Read more